Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in RNA — Atrium Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$527,937
-$56,289 QoQ
Shares Held
39,252
-10.2% QoQ
Ownership
0.229%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 87% Shared 0% None 13%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RNA ranks #238 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $527,937 39,252
2026-03-31 $584,226 43,697